ZEB1 is neither sufficient nor required for epithelial-mesenchymal transition in LS174T colorectal cancer cells

Biochemical and Biophysical Research Communications

Volumn 482, Issue 4, 2017, Pages 1226-1232

  Jägle, Sabine ^a   Dertmann, Annika ^a,c   Schrempp, Monika ^a   Hecht, Andreas ^a,b  

^a UNIVERSITY OF FREIBURG   (Germany)

^b UNIVERSITY OF FREIBURG   (Germany)

^c agap2 HIQ Consulting AG   (Switzerland)

Author keywords

Colorectal cancer; Epithelial mesenchymal transition; Genome editing; SNAIL1; Tumor cell invasion; ZEB1

Indexed keywords

CASPASE 9; TRANSCRIPTION FACTOR SNAIL; TRANSCRIPTION FACTOR ZEB1; CADHERIN; CDH1 PROTEIN, HUMAN; DOXYCYCLINE; OXALIPLATIN; PLATINUM COMPLEX; SNAI1 PROTEIN, HUMAN; ZEB1 PROTEIN, HUMAN;

ARTICLE; CANCER CELL; CANCER CELL LINE; CELL CULTURE; CELL GROWTH; CELL INVASION; CELL STRUCTURE; CHEMOSENSITIVITY; COLORECTAL CANCER; CONTROLLED STUDY; CRISPR CAS SYSTEM; ECTOPIC EXPRESSION; EPITHELIAL MESENCHYMAL TRANSITION; EPITHELIUM CELL; GENE EXPRESSION; MARKER GENE; PRIORITY JOURNAL; SPHEROID CELL; UPREGULATION; ADENOCARCINOMA; CELL PROLIFERATION; CELL SURVIVAL; CHEMISTRY; COLORECTAL TUMOR; DRUG RESISTANCE; GENE EXPRESSION REGULATION; HUMAN; METABOLISM; MULTICELLULAR SPHEROID; TUMOR CELL LINE; TUMOR INVASION;

ADENOCARCINOMA; CADHERINS; CELL LINE, TUMOR; CELL PROLIFERATION; CELL SURVIVAL; COLORECTAL NEOPLASMS; CRISPR-CAS SYSTEMS; DOXYCYCLINE; DRUG RESISTANCE, NEOPLASM; EPITHELIAL-MESENCHYMAL TRANSITION; GENE EXPRESSION REGULATION, NEOPLASTIC; HUMANS; NEOPLASM INVASIVENESS; ORGANOPLATINUM COMPOUNDS; SNAIL FAMILY TRANSCRIPTION FACTORS; SPHEROIDS, CELLULAR; UP-REGULATION; ZINC FINGER E-BOX-BINDING HOMEOBOX 1;

EID: 85008184047     PISSN: 0006291X     EISSN: 10902104     Source Type: Journal    
DOI: 10.1016/j.bbrc.2016.12.017     Document Type: Article

References (25)

1. [1] Nieto, M.A., Huang, R.Y., Jackson, R.A., Thiery, J.P., EMT. Cell 166:2016 (2016), 21–45.
2. [2] Moreno-Bueno, G., Peinado, H., Molina, P., Olmeda, D., Cubillo, E., Santos, V., Palacios, J., Portillo, F., Cano, A., The morphological and molecular features of the epithelial-to- mesenchymal transition. Nat. Protoc. 4 (2009), 1591–1613.
3. [3] Peinado, H., Olmeda, D., Cano, A., Snail, Zeb and bHLH factors in tumour progression: an alliance against the epithelial phenotype?. Nat. Rev. Cancer 7 (2007), 415–428.
4. [4] Batlle, E., Sancho, E., Francí, C., Domínguez, D., Monfar, M., Baulida, J., García De Herreros, A., The transcription factor snail is a repressor of E-cadherin gene expression in epithelial tumour cells. Nat. Cell Biol. 2 (2000), 84–89.
5. [5] Cano, A., Pérez-Moreno, M.A., Rodrigo, I., Locascio, A., Blanco, M.J., del Barrio, M.G., Portillo, F., Nieto, M.A., The transcription factor snail controls epithelial-mesenchymal transitions by repressing E-cadherin expression. Nat. Cell Biol. 2 (2000), 76–83.
6. [6] Zhang, P., Wei, Y., Wang, L., Debeb, B.G., Yuan, Y., Zhang, J., Yuan, J., Wang, M., Chen, D., Sun, Y., Woodward, W.A., Liu, Y., Dean, D.C., Liang, H., Hu, Y., Ang, K.K., Hung, M.-C., Chen, J., Ma, L., ATM-mediated stabilization of ZEB1 promotes DNA damage response and radioresistance through CHK1. Nat. Cell Biol. 16 (2014), 864–875.
7. [7] Rönsch, K., Jägle, S., Rose, K., Seidl, M., Baumgartner, F., Freihen, V., Yousaf, A., Metzger, E., Lassmann, S., Schule, R., Zeiser, R., Michoel, T., Hecht, A., SNAIL1 combines competitive displacement of ASCL2 and epigenetic mechanisms to rapidly silence the EPHB3 tumor suppressor in colorectal cancer. Mol. Oncol. 9 (2015), 335–354.
8. [8] Preca, B.T., Bajdak, K., Mock, K., Sundararajan, V., Pfannstiel, J., Maurer, J., Wellner, U., Hopt, U.T., Brummer, T., Brabletz, S., Brabletz, T., Stemmler, M.P., A self-enforcing CD44s/ZEB1 feedback loop maintains EMT and stemness properties in cancer cells. Int. J. Cancer 137 (2015), 2566–2577.
9. [9] Dave, N., Guaita-Esteruelas, S., Gutarra, S., Frias, A., Beltran, M., Peiro, S., de Herreros, A.G., Functional cooperation between Snail1 and twist in the regulation of ZEB1 expression during epithelial to mesenchymal transition. J. Biol. Chem. 286 (2011), 12024–12032.
10. [10] Tran, D.D., Corsa, C.A., Biswas, H., Aft, R.L., Longmore, G.D., Temporal and spatial cooperation of Snail1 and Twist1 during epithelial-mesenchymal transition predicts for human breast cancer recurrence. Mol. Cancer Res. 9 (2011), 1644–1657.
11. [11] Zhang, J., Tian, X.J., Zhang, H., Teng, Y., Li, R., Bai, F., Elankumaran, S., Xing, J., TGF-beta-induced epithelial-to-mesenchymal transition proceeds through stepwise activation of multiple feedback loops. Sci. Signal., 7, 2014, ra91.
12. [12] Hsu, P.D., Scott, D.A., Weinstein, J.A., Ran, F.A., Konermann, S., Agarwala, V., Li, Y., Fine, E.J., Wu, X., Shalem, O., Cradick, T.J., Marraffini, L.A., Bao, G., Zhang, F., DNA targeting specificity of RNA-guided Cas9 nucleases. Nat. Biotechnol. 31 (2013), 827–832.
13. [13] Mali, P., Yang, L., Esvelt, K.M., Aach, J., Guell, M., DiCarlo, J.E., Norville, J.E., Church, G.M., RNA-guided human genome engineering via Cas9. Science 339 (2013), 823–826.
14. [14] Schnappauf, O., Beyes, S., Dertmann, A., Freihen, V., Frey, P., Jagle, S., Rose, K., Michoel, T., Grosschedl, R., Hecht, A., Enhancer decommissioning by Snail1-induced competitive displacement of TCF7L2 and down-regulation of transcriptional activators results in EPHB2 silencing. Biochim. Biophys. Acta 1859 (2016), 1353–1367.
15. [15] Jägle, S., Rönsch, K., Timme, S., Andrlova, H., Bertrand, M., Jäger, M., Proske, A., Schrempp, M., Yousaf, A., Michoel, T., Zeiser, R., Werner, M., Lassmann, S., Hecht, A., Silencing of the EPHB3 tumor-suppressor gene in human colorectal cancer through decommissioning of a transcriptional enhancer. Proc. Natl. Acad. Sci. U. S. A. 111 (2014), 4886–4891.
16. [16] Ren, J., Chen, Y., Song, H., Chen, L., Wang, R., Inhibition of ZEB1 reverses EMT and chemoresistance in docetaxel-resistant human lung adenocarcinoma cell line. J. Cell. Biochem. 114 (2013), 1395–1403.
17. [17] Arumugam, T., Ramachandran, V., Fournier, K.F., Wang, H., Marquis, L., Abbruzzese, J.L., Gallick, G.E., Logsdon, C.D., McConkey, D.J., Choi, W., Epithelial to mesenchymal transition contributes to drug resistance in pancreatic cancer. Cancer Res. 69 (2009), 5820–5828.
18. [18] Cortina, C., Palomo-Ponce, S., Iglesias, M., Fernandez-Masip, J.L., Vivancos, A., Whissell, G., Huma, M., Peiro, N., Gallego, L., Jonkheer, S., Davy, A., Lloreta, J., Sancho, E., Batlle, E., EphB-ephrin-B interactions suppress colorectal cancer progression by compartmentalizing tumor cells. Nat. Genet. 39 (2007), 1376–1383.
19. [19] Chiu, S.-T., Chang, K.-J., Ting, C.-H., Shen, H.-C., Li, H., Hsieh, F.-J., Over-expression of EphB3 enhances cell-cell contacts and suppresses tumor growth in HT-29 human colon cancer cells. Carcinogenesis 30 (2009), 1475–1486.
20. [20] Nawshad, A., Hay, E.D., TGFbeta3 signaling activates transcription of the LEF1 gene to induce epithelial mesenchymal transformation during mouse palate development. J. Cell Biol. 163 (2003), 1291–1301.
21. [21] Guaita, S., Puig, I., Franci, C., Garrido, M., Dominguez, D., Batlle, E., Sancho, E., Dedhar, S., de Herreros, A.G., Baulida, J., Snail induction of epithelial to mesenchymal transition in tumor cells is accompanied by MUC1 repression and ZEB1 expression. J. Biol. Chem. 277 (2002), 39209–39216.
22. [22] Izawa, G., Kobayashi, W., Haraguchi, M., Sudo, A., Ozawa, M., The ectopic expression of Snail in MDBK cells does not induce epithelial-mesenchymal transition. Int. J. Mol. Med. 36 (2015), 166–172.
23. [23] Kim, K., Lu, Z., Hay, E.D., Direct evidence for a role of beta-catenin/LEF-1 signaling pathway in induction of EMT. Cell Biol. Int. 26 (2002), 463–476.
24. [24] Fischer, K.R., Durrans, A., Lee, S., Sheng, J., Li, F., Wong, S.T., Choi, H., El, R.T., Ryu, S., Troeger, J., Schwabe, R.F., Vahdat, L.T., Altorki, N.K., Mittal, V., Gao, D., Epithelial-to-mesenchymal transition is not required for lung metastasis but contributes to chemoresistance. Nature 527 (2015), 472–476.
25. [25] Sánchez-Tilló, E., Siles, L., de Barrios, O., Cuatrecasas, M., Vaquero, E.C., Castells, A., Postigo, A., Expanding roles of ZEB factors in tumorigenesis and tumor progression. Am. J. Cancer Res. 1 (2011), 897–912.